Mal-RSQSRSRYYRQRQRSRRRRRRS-NH2

Rif. 3D-PP49090

Informazioni sul prodotto

• Nome: Mal-RSQSRSRYYRQRQRSRRRRRRS-NH2

Descrizione

Peptide Mal-RSQSRSRYYRQRQRSRRRRRRS-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Mal-RSQSRSRYYRQRQRSRRRRRRS-NH2 include the following: Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells X Li , P Stuckert, I Bosch , JD Marks, WA Marasco - Cancer gene therapy, 2001 - nature.comhttps://www.nature.com/articles/7700337 Antibody-Mediated BRCC36 Silencing: A Novel Approach for Targeted Breast Cancer Therapy X Chen - 2010 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA513475 BRCA1-Associated Protein BRCC36: A Novel Target for Breast Cancer Therapy X Chen - 2008 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA520557 Optimizing Protein Purification for RNA-Binding Recombinant Fusion Proteins T Li - 2021 - search.proquest.comhttps://search.proquest.com/openview/9c15570b4764f0513f6ac112d38e0653/1?pq-origsite=gscholar&cbl=18750&diss=y Carrier-free CXCR4-targeted nanoplexes designed for polarizing macrophages to suppress tumor growth MB Deci, M Liu, J Gonya, CJ Lee, T Li - Cellular and Molecular , 2019 - Springerhttps://link.springer.com/article/10.1007/s12195-019-00589-w mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446 GD Bell , Y Yang, E Leung , GW Krissansen - PLoS One, 2018 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201464

• Marchio: Biosynth